Format

Send to

Choose Destination
Eur Respir J. 2018 May 10;51(5). pii: 1800445. doi: 10.1183/13993003.00445-2018. Print 2018 May.

Management appropriateness and outcomes of patients with acute pulmonary embolism.

Author information

1
Respiratory Dept, Hospital Ramón y Cajal and Dept of Medicine, Universidad de Alcalá (IRYCIS), Madrid, Spain.
2
These authors contributed equally.
3
Division of Cardiology, Dept of Medicine, Columbia University Medical Center, New York-Presbyterian Hospital, New York, NY, USA.
4
Center for Outcomes Research and Evaluation (CORE), Yale University School of Medicine, New Haven, CT, USA.
5
Biostatistics Dept, Hospital Ramón y Cajal (IRYCIS), CIBERESP, Madrid, Spain.
6
Respiratory Dept, Hospital Virgen del Rocío, Seville, Spain.
7
F. Edward Hebert School of Medicine, Uniformed Services University, Bethesda, MD, USA.
8
Dept of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
9
Division of Pulmonary and Critical Care Medicine and Division of General Medical Sciences, Washington University School of Medicine, St Louis, MO, USA.
10
Dept of Internal Medicine, Hospital Universitari Germans Trias i Pujol, Barcelona, Spain.
11
Dept of Medicine, Universidad Católica de Murcia, Murcia, Spain.

Abstract

The impact of adherence to published guidelines on the outcomes of patients with acute pulmonary embolism (PE) has not been well defined by previous studies.In this prospective cohort study of patients admitted to a respiratory department (n=2096), we evaluated whether patients with PE had better outcomes if they were acutely managed according to international guidelines. Outcomes consisted of all-cause mortality, PE-related mortality, recurrent venous thromboembolism (VTE) and major bleeding events during the first month of follow-up after diagnosis.Overall, 408 patients (19% (95% CI 18-21%)) did not receive guideline-adherent PE management. Patients receiving non-adherent management were significantly more likely to experience all-cause mortality (adjusted odds ratio (OR) 2.39 (95% CI 1.57-3.61) or PE-related mortality (adjusted OR 5.02 (95% CI 2.42-10.42); p<0.001) during follow-up. Non-adherent management was also a significant independent predictor of recurrent VTE (OR 2.19 (95% CI 1.11-4.32); p=0.03) and major bleeding (OR 2.65 (95% CI 1.66-4.24); p<0.001). An external validation cohort of 34 380 patients with PE from the RIETE registry confirmed these findings.PE management that does not adhere to guidelines for indications related to anticoagulation, thrombolytics and inferior vena cava filters is associated with worse patient outcomes.

PMID:
29724918
DOI:
10.1183/13993003.00445-2018
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for HighWire
Loading ...
Support Center